## Vision & Problem

**Founding Vision and Origin Story**

Medcol was born out of a deeply personal space—family dinners where complex medical cases were discussed by founder Leonid Klarov’s physician relatives. This exposure revealed how clinical reasoning, not just knowledge, drives real decision-making in medicine. The goal became clear: build a system that supports doctors in thinking better, not just faster.

**The Core Healthcare Problem Medcol Addresses**

Doctors are overwhelmed with fragmented data, lack time for proper reasoning, and face increasing burnout. Patients experience non-personalized care and inconsistent outcomes. Existing AI tools often provide static or generic answers, lacking true clinical understanding.

**Why Now: Market Timing and Urgency**

Telemedicine is scaling rapidly, but without clinical intelligence. LLMs are now powerful enough to assist in medical decision-making, and digital health adoption is accelerating globally. Regulatory frameworks are maturing, and the demand for scalable, quality care has never been greater.

---

### Problem

Medcol solves the problem of fragmented, time-consuming clinical workflows by automating pre-visit data collection and supporting doctors with structured AI-driven reasoning, reducing cognitive load and improving care quality.

## Solution & Product

**What Medcol Does**

Medcol is an AI-powered clinical reasoning platform that supports doctors through the entire patient journey: pre-visit intake, differential diagnosis (DDx), personalized treatment planning (Tx), real-time documentation, and follow-ups.

**Unique Approach**

Medcol uses a proprietary system — a multi-agent architecture where each AI agent simulates the perspective of a specialist (e.g., cardiologist, neurologist). They collaboratively reason through complex cases using a shared structured knowledge base called **MedGraph**, which allows contextual and traceable decision-making.

All of this runs through an LLM-based pipeline tailored for clinical workflows, unlike off-the-shelf solutions.

—

### Unique

Medcol’s solution is unique through its **multi-agent clinical reasoning system**, which replicate the collaborative thinking of medical teams. Unlike generic chatbots, Medcol integrates deeply into clinical workflows, providing context-aware, structured insights during pre-visit, diagnosis, and follow-up stages.

—

**What Makes Medcol Different from Tools Like ChatGPT**

ChatGPT provides general answers; Medcol offers **structured, agent-based reasoning** tied to medical logic and guidelines. Instead of "text completion," Medcol simulates clinical thought, includes audit trails, and integrates with medical records, ensuring safety, clarity, and trust.

**User Experience**

Doctors don’t need to change how they work—Medcol integrates directly into EHR systems and telemedicine platforms. It auto-generates summaries, flags key risks, suggests relevant diagnostics, and supports next-step planning—all while remaining in the doctor’s control.

## Technology & Architecture

**How ConSilico Works**

At the core of Medcol is **ConSilico** — a multi-agent AI system that mirrors the way real doctors think in teams. Each agent represents a medical specialty (like cardiology or neurology) and contributes its perspective to simulate a clinical concilium. This layered reasoning allows for nuanced, safe, and explainable decision support.

**MedGraph: The Engine Behind Clinical Intelligence**

To support meaningful reasoning, agents operate on **M-Graph** — a structured, dynamic knowledge graph built from trusted clinical sources, guidelines, and real-world patterns. Unlike traditional LLMs, MedGraph ensures traceability, logical flow, and consistent clinical context in every output.

**Advanced LLM Stack and Optimization**

Medcol leverages fine-tuned language models optimized for healthcare dialogue, with inference pipelines engineered for low latency and high accuracy. The platform is modular, cloud-ready, and compatible with standards like **FHIR** and **HL7**, enabling smooth integration with hospital and telemedicine systems.

**Built with Trust in Mind**

We prioritize **security, privacy, and regulatory compliance** from the ground up. Medcol adheres to **HIPAA** and **GDPR** standards, employs data anonymization techniques, and supports secure, auditable interactions between patient data and AI.

---

## Traction & Adoption

**Early Integrations in Action**

Medcol is already embedded into Kazakhstan’s national **eGov healthcare portal**, powering AI-assisted patient intake and triage for millions of citizens. We’ve also integrated with private health innovators like **CheckDoc** and **ValeoHealth**, proving our ability to work across both public and private ecosystems.

**Pilot Deployments and Usage Data**

Live pilots have demonstrated operational feasibility and scalability. Initial deployments have processed thousands of real patient interactions, providing valuable feedback loops for refinement and validation.

**Professional Endorsement at Scale**

More than **300 medical professionals** have tested and provided feedback on Medcol, helping shape its evolution to meet real-world clinical needs. Their continued engagement is a sign of both credibility and demand.

**Global Outlook**

Strategic partnerships are in development across **GCC countries, Africa, and Southeast Asia**, where digital transformation is accelerating and the need for intelligent clinical infrastructure is immediate.

## Market Opportunity

**A Market on the Move**

The global **AI in healthcare market** is expanding at a **CAGR of over 40%**, expected to reach **$188 billion by 2030**. Clinical decision support, triage automation, and virtual care are among the fastest-growing verticals.

**A Perfect Storm of Demand**

Healthcare systems globally are facing clinician shortages, rising costs, and increasing demand for personalized care. Medcol is positioned at the intersection of **telemedicine**, **remote diagnostics**, and **AI-augmented clinical workflows**—delivering value where the need is most acute.

**Market Sizing**

Our **TAM** (Total Addressable Market) spans global digital health platforms, with **SAM** focused on telehealth and EMR integrations in **GCC, Central Asia, and Africa**. The initial **SOM** targets B2B deployments with early adopters in government and private digital health operators.

---

## Business Model

**SaaS First, Enterprise Ready**

Medcol operates as a **B2B SaaS platform** through **API subscriptions** and **enterprise licensing**. Telemedicine platforms, insurance companies, and health systems pay for access to our AI decision support engine.

**Custom Deployments for Scale**

For large clients like government portals or hospital networks, we offer **white-label integrations, custom workflows**, and **clinical consulting** to support change management and internal adoption.

**Scalable Growth Strategy**

Our infrastructure and product roadmap are built for **modular scalability**—from embedding in small clinic EMRs to full integration within **national digital health ecosystems**.

---

## Team & Leadership

**Founder-Led, Deeply Technical**

- **Leonid Klarov**, CEO — Former radiologist, founder of AI diagnostics lab in Yakutia, speaker at **ESR**, with deep roots in clinical AI.
- **Anatoly Mariev**, CBDO — MIT Alumni. Former digital transformation lead in banking, with fintech AI experience, now driving Medcol’s operations and business development.
- **Senior Engineering Team** — 10–15 years each in AI, NLP, and high-load architecture, working across edge deployments and real-time clinical systems.

**Advisory Network in Motion**

We are building a **clinical and scientific advisory board**, drawing from our pilot partners and AI research collaborators to ensure alignment with frontline needs and emerging tech standards.

# Phrases:

idea

Everyone is building AI to think *like one doctor*. Medcol asks: what if we think like a **team**? We’re turning clinical reasoning into a collaborative process — before the visit even starts. Our system prepares the case like a medical intern, thinks through it like a panel of specialists, and hands the doctor clarity, not chaos. It’s not automation — it’s augmentation, designed to make every decision feel obvious

---

Medcol is building an AI-powered clinical reasoning platform that helps healthcare providers automate pre-visit data collection and deliver personalized, evidence-based decision support. Our mission is to bring clarity to clinical workflows, reduce physician burden, and improve patient outcomes through structured, multi-agent AI systems that replicate real-world medical teamwork.

---

### **YoY Revenue Growth for GTM Speech**

Medcol is on a high-growth trajectory with projected revenue surging from **$309K in 2025 to $39.7M by 2028**. With a **YoY growth exceeding 100%**, our business model scales rapidly as we expand from **10 clients in 2025 to 121 in 2028**, fueled by **B2B SaaS contracts and enterprise integrations**. The **AI healthcare market is booming**, and Medcol is positioned to capitalize on this momentum, **driving efficiency, reducing costs, and delivering high-impact AI-powered clinical reasoning.**

---

### **Medcol – AI-Powered Clinical Reasoning for Smarter Healthcare**

Medcol is an **AI-driven clinical reasoning platform** designed to **streamline pre-visit triage, enhance diagnosis, and automate follow-ups**, making healthcare more **efficient and personalized**. By leveraging multi-agent AI, Medcol **optimizes patient workflows for doctors and telemedicine providers**, reducing cognitive load and improving decision-making. Integrated with **HL7/FHIR standards**, our system seamlessly fits into existing **EHRs, telemedicine platforms, and hospital networks**, ensuring regulatory compliance and scalable adoption. **Trusted by government and private healthcare providers**, Medcol is redefining **how AI supports clinicians—delivering better insights, faster workflows, and improved patient outcomes.**

---

Thank you for taking the time to go through our deck and for your thoughtful questions. Here are our answers:

### **Valuation, Fundraising & Financial Model**

- We are currently raising **$1M at a $5M valuation**. The funds will be deployed to **enhance AI capabilities, expand integrations with healthcare providers, and drive regulatory compliance for scaling in key markets**.
- The funds will cover **18 months** and be used for:
    - **60% Product & AI development** (enhancing multi-agent clinical reasoning, refining pre-visit automation).
    - **20% Market expansion & partnerships** (scaling GCC & Central Asia).
    - **10% Compliance & certifications** (regulatory approvals in key markets).
    - **10% Operational scaling** (support team & infrastructure).
- Our financial model projects **$10K per B2B client monthly**, scaling from 10 clients in 2025 to 121 clients in 2028, with revenue growing **90% YoY**. By **2026, we expect to break even.**

### **Funding History & Implementations**

- **Bootstrapped + angel backing**: We initially raised **$250K in angel funding** (ex-C-level pharma executive) to build and launch our AI model.
- Strategic **pilot deployments**: We secured **government-backed implementations** in Kazakhstan (eGov integration), as well as pilots with **Valeo Health and Checkdoc**, leveraging partnerships rather than heavy financial investment.

### **Regulatory & Compliance Strategy**

- We **do not prescribe treatment directly**—Medcol functions as a **clinical decision support system (CDSS)**, ensuring **doctors remain in control** while benefiting from AI-driven insights.
- **Malpractice risk mitigation**: We align with **HL7/FHIR standards**, focusing on **pre-visit preparation, structured decision support, and documentation automation** rather than direct treatment recommendations.
- Compliance roadmap: **EU MDR, UAE MOH approvals** in progress, ensuring we meet jurisdictional requirements while avoiding liability pitfalls.

---

Big problem - "Pre-Visit Cognitive Scramble"?

Problem Statement (Narrowed, Non-Obvious, Big):

"The single most inefficient step in healthcare isn't during the patient visit; it's the cognitive scramble doctors face before it starts. Clinicians waste critical minutes per encounter piecing together fragmented data 'cold', leading to rushed initial judgments and diagnostic pathways seeded with inefficiency from the outset. Existing EHRs are just passive databases, and current AI fails at proactive case synthesis. This ubiquitous 'pre-visit' friction point, multiplied across millions of daily encounters, represents billions in lost physician productivity and downstream costs – a massive, chronically overlooked bottleneck ripe for intelligent automation."